Reference
1. Yamagata K, Ishida K,
Sairenchi T et al. Risk factors for chronic kidney disease in a
community-based population: a 10-year follow-up study. Kidney
international 2007; 71: 159-66.
2. Whelton PK, Carey RM,
Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA
Guideline for the Prevention, Detection, Evaluation, and Management of
High Blood Pressure in Adults: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice
Guidelines. Hypertension (Dallas, Tex : 1979) 2018; 71:
e13-e115.
3. Kastarinen M, Juutilainen
A, Kastarinen H et al. Risk factors for end-stage renal disease in a
community-based population: 26-year follow-up of 25,821 men and women in
eastern Finland. Journal of internal medicine 2010; 267: 612-20.
4. Haroun MK, Jaar BG, Hoffman
SC et al. Risk factors for chronic kidney disease: a prospective study
of 23,534 men and women in Washington County, Maryland. Journal of
the American Society of Nephrology : JASN 2003; 14: 2934-41.
5. Hsu CY, McCulloch CE,
Darbinian J et al. Elevated blood pressure and risk of end-stage renal
disease in subjects without baseline kidney disease. Archives of
internal medicine 2005; 165: 923-8.
6. Tozawa M, Iseki K, Iseki C
et al. Blood pressure predicts risk of developing end-stage renal
disease in men and women. Hypertension (Dallas, Tex : 1979) 2003;
41: 1341-5.
7. Iseki K. Predictors of
diabetic end-stage renal disease in Japan. Nephrology (Carlton,
Vic) 2005; 10 Suppl: S2-6.
8. Osawa T, Fujihara K, Harada
M et al. Higher pulse pressure predicts initiation of dialysis in
Japanese patients with diabetes. Diabetes/metabolism research and
reviews 2019; 35: e3120.
9. Kimura S, Sato T, Ikeda S
et al. Development of a database of health insurance claims:
standardization of disease classifications and anonymous record linkage.Journal of epidemiology 2010; 20: 413-9.
10. Fujihara K, Igarashi R,
Yamamoto M et al. Impact of glucose tolerance status on the development
of coronary artery disease among working-age men. Diabetes &
metabolism 2016.
11. Hsieh MC, Hsieh YT, Cho
TJ et al. Remission of diabetic nephropathy in type 2 diabetic Asian
population: role of tight glucose and blood pressure control.European journal of clinical investigation 2011; 41: 870-8.
12. Sheen YJ, Lin JL, Li TC
et al. Systolic blood pressure as a predictor of incident albuminuria
and rapid renal function decline in type 2 diabetic patients.Journal of diabetes and its complications 2014; 28: 779-84.
13. Zoppini G, Targher G,
Chonchol M et al. Predictors of estimated GFR decline in patients with
type 2 diabetes and preserved kidney function. Clinical journal of
the American Society of Nephrology : CJASN 2012; 7: 401-8.
14. Ushigome E, Hamaguchi M,
Matsumoto S et al. Optimal home SBP targets for preventing the
progression of diabetic nephropathy in patients with type 2 diabetes
mellitus. Journal of hypertension 2015; 33: 1853-9; discussion
9.
15. Rossing K, Christensen
PK, Hovind P et al. Progression of nephropathy in type 2 diabetic
patients. Kidney international 2004; 66: 1596-605.
16. Report of the Committee
on the Classification and Diagnostic Criteria of Diabetes Mellitus:
Revision for International Harmonization of HbA1c in Japan: Journal of
the Japan Diabetes Society. 2012; 7: 485-504.
17. Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet
(London, England) 1998; 352: 837-53.
18. Nathan DM, Genuth S,
Lachin J et al. The effect of intensive treatment of diabetes on the
development and progression of long-term complications in
insulin-dependent diabetes mellitus. The New England journal of
medicine 1993; 329: 977-86.
19. Ohkubo Y, Kishikawa H,
Araki E et al. Intensive insulin therapy prevents the progression of
diabetic microvascular complications in Japanese patients with
non-insulin-dependent diabetes mellitus: a randomized prospective 6-year
study. Diabetes research and clinical practice 1995; 28: 103-17.
20. Beddhu S, Greene T,
Boucher R et al. Intensive systolic blood pressure control and incident
chronic kidney disease in people with and without diabetes mellitus:
secondary analyses of two randomised controlled trials. The lancet
Diabetes & endocrinology 2018; 6: 555-63.
21. Cushman WC, Evans GW,
Byington RP et al. Effects of intensive blood-pressure control in type 2
diabetes mellitus. The New England journal of medicine 2010; 362:
1575-85.
22. Rahman F, McEvoy JW,
Ohkuma T et al. Effects of Blood Pressure Lowering on Clinical Outcomes
According to Baseline Blood Pressure and Cardiovascular Risk in Patients
With Type 2 Diabetes Mellitus. Hypertension (Dallas, Tex : 1979)2019; 73: 1291-9.
23. Management of Diabetic
Patients on Hemodialysis. 2012.
Table 1. Characteristics
of study participants according to presence or absence of diabetes and
dialysis